[Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D001884:Bordetella / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D066298:In Vitro Techniques; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008089:Listeria monocytogenes / Q000187:drug effects; D008088:Listeriosis / Q000188:drug therapy; D051379:Mice; D008826:Microbial Sensitivity Tests; D011008:Pneumococcal Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011513:Proteus mirabilis / Q000187:drug effects; D011514:Proteus vulgaris / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D012486:Salmonella typhimurium / Q000187:drug effects; D012505:Sarcina / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D012293:Rifampin
Antibakterial'noe deĭstvie rifampitsina i ego khimoterapevticheskie svoĭstva v opytakh na zhivotnykh